Eason Technology Limited Receives Notification from NYSE Regarding Delinquent Filing of its Semi-annual Financials
Rhea-AI Summary
Eason Technology (NYSE: DXF) received notice from NYSE Regulation that it failed to timely file its Form 6-K containing semi-annual financials for the period ended June 30, 2025, missing the Dec 31, 2025 filing deadline. The company said the delay resulted from completing its financial statements and that it is working to file the Interim Report within the Initial Cure Period through June 30, 2026. ADSs remain listed and tradable during the cure period, but failure to cure could lead to suspension and delisting or a possible additional cure period to Dec 31, 2026.
Positive
- ADSs remain listed and tradable during the cure period
- Company is actively working to file the Interim Report within the cure period
Negative
- Failed to file Form 6-K for half year ended June 30, 2025
- Subject to NYSE American delisting procedures if noncompliant after cure periods
- Initial Cure Period ends June 30, 2026; additional cure to Dec 31, 2026 possible
News Market Reaction
On the day this news was published, DXF declined 8.44%, reflecting a notable negative market reaction. Argus tracked a trough of -8.9% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $288K from the company's valuation, bringing the market cap to $3M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
DXF showed company-specific movement while momentum data flagged only FOA with a move of about 7.28% upward, indicating the reaction was not part of a broad Credit Services rotation.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 20 | NYSE non-compliance | Negative | +3.5% | Notice of noncompliance due to low equity and multi-year losses. |
| Oct 08 | Equity incentives | Positive | -2.1% | Issuance of incentive ADSs and lock-up commitment by management. |
| Sep 26 | Compliance regained | Negative | -31.1% | Regained NYSE compliance but with auditor going concern emphasis. |
| Sep 24 | Annual report filing | Neutral | -1.0% | Form 20-F filing providing audited 2024 financial statements. |
DXF’s past NYSE compliance headlines often saw share moves that diverged from the apparent tone of the news, with both positive and negative items sometimes triggering selling.
Over the last several months, DXF has repeatedly interacted with NYSE American listing standards. On Sep 24, 2025, it filed its 2024 Form 20-F, followed by a Sep 26, 2025 announcement that it had regained compliance with Section 1007, though auditors included a going concern emphasis. In Oct 2025, the company issued incentive ADSs under a 2025 plan and later disclosed a non-compliance notice tied to low stockholders’ equity and losses. Today’s delinquent filing notice extends this pattern of listing-related risk.
Market Pulse Summary
The stock moved -8.4% in the session following this news. A negative reaction despite prior rebounds on NYSE compliance headlines would fit DXF’s fragile backdrop. The company had already received a non-compliance letter tied to low equity and losses and regained compliance only recently with a going concern emphasis noted by auditors. A fresh delinquent filing notice extending cure periods to as late as December 31, 2026 may have reinforced concerns over reporting controls and listing risk.
Key Terms
form 6-k regulatory
nyse american regulatory
ads financial
AI-generated analysis. Not financial advice.
NYSE Regulation notified the Company that NYSE American will closely monitor the status of the Company's Interim Report and any subsequent delayed filings for a six-month period from the date of the Filing Delinquency until June 30, 2026 (the "Initial Cure Period"). If the Company fails to cure the Filing Delinquency within the Initial Cure Period, the Exchange may, in its sole discretion, allow the Company's securities to be traded for up to an additional six-month period until December 31, 2026 (the "Additional Cure Period") depending on the Company's specific circumstances. If the Exchange determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set out in Section 1010 hereof. If the Exchange determines that an Additional Cure Period of up to six months is appropriate and the Company fails to file the Interim Report and any subsequent delayed filings by the end of that period, suspension and delisting procedures will generally commence.
The Company was not able to, without unreasonable effort or expense, to make the required filing by December 31, 2025, as a result of a delay in completing its financial statements for the half year ended June 30, 2025. The Company is making all efforts to file the Interim Report as soon as possible and within the Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable Exchange listing standards.
This delinquency notice has no immediate impact on the listing of the Company's ADSs, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.
About Eason Technology Limited
Eason Technology Limited is a company engaged in real estate operation management and investment and digital technology security business in
Safe Harbor Statement
Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information speaks only as of the date of this release.
View original content:https://www.prnewswire.com/news-releases/eason-technology-limited-receives-notification-from-nyse-regarding-delinquent-filing-of-its-semi-annual-financials-302657515.html
SOURCE Eason Technology Limited
FAQ
What filing did Eason Technology (DXF) miss and for what period?
Will Eason Technology ADSs (DXF) stop trading after the delinquency notice?
How long is the NYSE Initial Cure Period for DXF to regain compliance?
What happens if DXF does not file by June 30, 2026?
Why did Eason Technology fail to file the Interim Report by Dec 31, 2025?
Does the NYSE notice mean DXF is already delisted?
